S. Korea approves Celltrion's antibody COVID-19 treatment

S. Korea approves Celltrion's antibody COVID-19 treatmentПодробнее

S. Korea approves Celltrion's antibody COVID-19 treatment

S. Korea regains "full democracy" status / Celltrion's COVID-19 treatment approved / LOONAПодробнее

S. Korea regains 'full democracy' status / Celltrion's COVID-19 treatment approved / LOONA

S. Korea grants approval for locally-developed COVID-19 antibody treatmentПодробнее

S. Korea grants approval for locally-developed COVID-19 antibody treatment

Celltrion's COVID-19 treatment gets conditional approval for medium and high-risk patientsПодробнее

Celltrion's COVID-19 treatment gets conditional approval for medium and high-risk patients

COVID-19 treatment made by S. Korea's Celltrion under reviewПодробнее

COVID-19 treatment made by S. Korea's Celltrion under review

S. Korea's Celltrion COVID-19 antibody drug ready for useПодробнее

S. Korea's Celltrion COVID-19 antibody drug ready for use

Celltrion's Covid-19 antibody drug cut recovery time-early studyПодробнее

Celltrion's Covid-19 antibody drug cut recovery time-early study

U.S. FDA approves S. Korea's Celltrion COVID-19 test kitПодробнее

U.S. FDA approves S. Korea's Celltrion COVID-19 test kit

S. Korea's Celltrion to start phase 1 test vaccine testing on patients with COVID symptomsПодробнее

S. Korea's Celltrion to start phase 1 test vaccine testing on patients with COVID symptoms

Актуальное